FDA green lights algorithm for detecting heart arrhythmia

The U.S. Food and Drug Administration has approved a software algorithm that detects atrial fibrillation on a mobile heart monitor.

AliveCor's automated analysis process, called AFib, can determine atrial fibrillation events using electrocardiogram recordings on its mobile phone-based Heart Monitor. The results can then be confirmed using the company's ECG analysis service, according to an announcement.

"The ability to automatically detect serious heart arrhythmia using mobile technology has the potential to save lives, reduce healthcare costs and allow patients and their caregivers to make informed decisions about cardiac care," said Euan Thomson, AliveCor president and CEO, in the announcement.

The company plans to make AFib Detector available by next month. Its Heart Monitor is compatible with all iPhone models and most Android mobile devices. Announcement

Suggested Articles

The newly launched Center for Connected Health will be largest telehealth hub in the Philadelphia region, according to Penn Medicine.

The FDA commissioner wants to use additional funding under Trump's budget to advance digital health initiatives and integrate real-world data.

The FDA's approval of an app that uses AI to notify specialists of a potential stroke offers new possibilities for triage software that uses CDS.